InsiderDB

Lobbying disclosures · Lobbying report

BMY: third_quarter 2026 lobbying report

Education regarding the value of biopharmaceutical innovation and related issues.

Follow BMY
Became public
Aug 4, 2026, 3:33 PM EDT
Event / period date
Not stated
Collected
Nov 10, 2026, 7:10 PM EST

Why this is connected

Legal-name match: BRISTOL-MYERS SQUIBB COMPANY is BRISTOL MYERS SQUIBB CO (https://www.sec.gov/Archives/edgar/data/14272/), differing only in punctuation, "the" or suffix spelling (Corp/Corporation).

Source evidence

Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/8fee6a5f-02af-490f-8b31-3aecbd3cfd9d/","filing_uuid":"8fee6a5f-02af-490f-8b31-3aecbd3cfd9d","filing_type":"RR","filing_type_display":"Registration","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/8fee6a5f-02af-490f-8b31-3aecbd3cfd9d/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Matt McGinley","dt_posted":"2026-08-04T15:33:29-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"2503-D Harrison Street North #1210","registrant_address_2":null,"registrant_different_address":null,"registrant_city":"Arlington","registrant_state":"VA","registrant_zip":"22207","registrant":{"id":401103524,"url":"https://lda.gov/api/v1/registrants/401103524/","house_registrant_id":null,"name":"ADVANCED POLICY CONSULTING, LLC","description":"Consulting","address_1":"2503-D Harrison Street North #1210","address_2":null,"address_3":null,"address_4":null,"city":"Arlington","state":"VA","state_display":"Virginia","zip":"22207","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MATT MCGINLEY","contact_telephone":"+1 703-536-1705","dt_updated":"2026-07-24T11:29:57.639066-04:00"},"client":{"id":74445,"url":"https://lda.gov/api/v1/clients/74445/","client_id":74445,"name":"BRISTOL-MYERS SQUIBB COMPANY","general_description":"Biopharmaceutical company","client_government_entity":null,"client_self_select":false,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2026-07-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Education regarding the value of biopharmaceutical innovation and related issues.","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":62356,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"MCGINLEY","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, Rep. Tom Price; Chief of Staff, Republican Policy Committee; DCOS & LD, Rep. Brian Kerns","new":true}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}

Congressional trading in BMY

These disclosures provide context. Their presence does not establish a link between a trader and the event.

Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.